Korean J Urol. 2011 Sep;52(9):622-625. English.
Published online Sep 28, 2011.
© The Korean Urological Association, 2011
Original Article

Differences in Urinary Stone Composition according to Body Habitus

Ji Yun Jeong, Seung Whan Doo, Won Jae Yang, Kwang Woo Lee,1 and Jun Mo Kim1
    • Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
    • 1Department of Urology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
Received May 26, 2011; Accepted July 19, 2011.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose

We analyzed differences in urinary stone composition according to body mass index (BMI).

Materials and Methods

Between January 2007 and December 2010, 505 ureteral or renal stones were collected from 505 patients who underwent surgical intervention. Data on patient age, gender, BMI, urinary pH, and stone composition were collected.

Results

The patients' mean age was 49.2 years (range, 20 to 83 years). Of the 505 patients, 196 (38.7%) had calcium oxalate (CO) stones, 172 (33.9%) had mixed calcium oxalate and calcium phosphate (COP) stones, 72 (14.2%) had calcium phosphate (CP) stones, 50 (9.8%) had uric acid (UA) stones, and 15 (2.9%) had struvite stones. We excluded struvite stones in the statistical analysis because of the small number of patients; a total of 490 patients were included in this study. In the multinomial logistic regression analysis, obesity was found to be associated with UA stones compared with COP stones (odds ratio [OR] 3.488; 95% confidence interval [CI] 1.732-7.025; p<0.001) and CP stones (OR 2.765; 95% CI 1.222-6.259; p=0.015). Similar results were observed for CO stones compared with COP stones (OR 2.682; 95% CI 1.727-4.164; p<0.001) and CP stones (OR 2.126; 95% CI 1.176-3.843; p<0.013).

Conclusions

Obesity was associated with UA and CO stones compared with the occurrence of COP and CP stones.

Keywords
Body mass index; Obesity; Urinary calculi

INTRODUCTION

The etiology of urinary stone disease is multifactorial and not completely well understood [1, 2]. Obesity appears to play an important role in the etiology of some well-known diseases, such as diabetes, hypertension, coronary artery disease, thromboembolism, lower back pain, osteoarthritis, and depression [3]. In addition, studies performed in recent years have demonstrated that people who are overweight or obese might also be prone to increased urinary stone formation [4-8]. Obesity is associated with insulin resistance and compensatory hyperinsulinemia, metabolic derangements that may lead to overly acidic urine [8, 9]. A persistently low urinary pH (≤5.5) is a distinctive feature of idiopathic uric acid (UA) stones [10]. Impaired ability to excrete acid in low urinary pH could result in hypocitraturia, which is an important risk factor for calcium stones [11]. Also, calcium oxalate (CO) stones may develop by heterogeneous nucleation of CO by UA [12, 13]. In addition to a lower urinary pH, recent studies have shown that obesity is associated with unique changes in serum and urinary chemistry such as increased urinary excretion of calcium, citrate, sulfate, phosphate, oxalate, UA, and cystine in stone formers [14-17].

Herein, we evaluated differences in urinary stone composition according to body habitus by use of body mass index (BMI).

MATERIALS AND METHODS

Between January 2007 and December 2010, we collected 505 urinary stones (ureteral or renal) from 505 adult patients who underwent surgical intervention (ureteroscopy, percutaneous nephrolithotomy, laparoscopic ureterolithotomy) at two hospitals located in the metropolitan area of South Korea. The composition of the collected stones was analyzed by spectroscopy. Each stone sample was washed and dried. A small portion (1 mg) of each stone sample was mixed with potassium bromide (200 mg KBr), which was powdered and then pressed into a small tablet. The tablet was then analyzed by spectroscopy. We classified the specimens as CO stones, mixed CO and calcium phosphate (COP) stones, or calcium phosphate (CP) stones according to the results of the analysis, which indicated the presence of calcium, oxalate, or phosphate regardless of mixed UA components. If the results revealed the presence of UA components only, or UA mixed with calcium components only, those stones were classified as UA stones.

The patients' data including age, gender, BMI, first urinary pH before surgical intervention, and urinary stone composition were recorded in a retrospective database. BMI was calculated by dividing the weight (kilograms) by the square of the height (meters). Individual BMI values were stratified into two categories (obese ≥, non-obese <25 kg/m2) developed for Asia-Oceanian populations [18]. Statistical analysis was performed by using SPSS ver. 14.0 (SPSS Inc., Chicago, IL, USA). A p-value was calculated by using the independent t-test for continuous variables and the Pearson chi-square test for categorical variables. Multinomial logistic regression was used to determine the associated factors for each urinary stone component. A p-value of less than 0.05 was considered statistically significant.

RESULTS

The patients' mean age was 49.2 years (range, 20 to 83 years). Of the 505 patients, 196 (38.7%) had CO stones, 172 (33.9%) had COP stones, 72 (14.2%) had CP stones, 50 (9.8%) had UA stones, and 15 (2.9%) had struvite stones. Among the CO and COP stone formers, 20 (10.2%) and 4 (2.3%) patients had UA components in their specimens, respectively. Among 50 patients having UA stones, 34 (68%) had pure UA stones, whereas the remaining 16 (32%) patients had mixed calcium components only besides UA.

We did not include struvite stones in the statistical analysis because of the small number of patients; a total of 490 patients were included in this study. The urinary pH of obese patients was significantly lower than that of non-obese patients (p<0.001) (Table 1). According to the univariate analysis, UA stones were significantly correlated with older age (≥50 years), lower urinary pH (≤5.5), and obesity. The stone composition differed significantly among the nonobese and obese groups. Obese patients tended to have a greater percentage of UA and CO stones but a lower percentage of COP and CP stones (Table 2).

TABLE 1
Characteristics of the study population by body habitus

TABLE 2
Univariate analysis between stone components and other clinical parameters

Multinomial logistic regression analysis revealed obesity to be associated with UA stones compared with COP stones (odds ratio [OR] 3.488; 95% confidence interval [CI] 1.732-7.025; p<0.001) and CP stones (OR 2.765, 95% CI 1.222-6.259; p=0.015) (Table 3). Similar results were observed for CO stones compared with COP stones (OR 2.682; 95% CI 1.727-4.164; p<0.001) and CP stones (OR 2.126; 95% CI 1.176-3.843; p<0.013). Lower urinary pH (≤5.5) was associated with UA stones compared with COP, CP, and even CO stones (OR 4.040; 95% CI 2.044-7.985; p<0.001). Increased age was associated with UA stones compared with all other types of urinary stones (Table 3).

TABLE 3
Multinomial logistic regression analysis between components of urinary stones and various clinical parameters

DISCUSSION

The incidence of urinary stones has markedly increased during the past several decades, and studies have demonstrated that inappropriate dietary habits and the increasing prevalence of overweight people may be important in the etiology of stone formation [4-8]. Urinary stones can have different components such as CO, CP, UA, struvite, and a mixture of these. An association between the different urinary stone component types and obesity has not previously been well documented.

Recent studies have revealed that obesity is associated with change in the chemical components of serum and urine such as citrate, phosphate, oxalate, and UA. Above all, obesity are associated with acidic urine. In this study, the mean urinary pH of obese patients (6.04) was significantly lower than that of nonobese patients (6.39; p<0.001). Although the exact mechanism is unclear, a possible explanation for the decline in urinary pH with obesity is insulin resistance, which decreases renal ammonia excretion and impairs hydrogen ion buffering. Low insulin bioactivity (due to insulin resistance from obesity) in the renal proximal tubule can theoretically lead to defective ammonium production or excretion, thus affecting urinary pH [20]. A low urinary pH (≤5.5) is a distinctive feature of UA stones [10]. The low urinary pH characteristic of idiopathic UA stone formers was shown by Sakhaee and Maalouf to be associated with decreased ammonium excretion, which by itself may be a renal manifestation of insulin resistance [21]. Confirming this hypothesis, our data provide evidence of the significant influence of increasing BMI on the risk of forming UA stones compared with COP and CP stones according to the multinomial logistic regression analysis. The proportion of UA stones was over two times higher in obese patients than in lean patients. In addition, older age (≥50 years) was found to be another factor significantly associated with UA stones. Because decreased ammonium excretion resulting in a lower urinary pH is frequently seen in the elderly, age-associated defective urinary acidification may be the major contributing factor for older subjects [22, 23]. The prevalence of insulin resistance also increases with age [24].

This study also revealed that a higher BMI was significantly associated with CO stone formation compared with COP and CP stones. The common hypothesis was that obese patients, due to high food intake, may have higher urinary excretion of lithogenic solutes, especially oxalate, calcium, and UA. Increased urinary UA excretion is not only associated with UA stone formation, but also poses a risk factor for CO stone formation because CO stones may develop by the salting-out effect in a hyperuricosuria environment [25, 26]. A decrease in urine pH leads to decreased production of CP crystals, which results in a relative increase in the formation of CO stones [27]. Our analysis revealed a correlation between the prevalence of CO stones and lower urinary pH compared with CP (OR 4.641; 95% CI 1.989-10.827; p<0.001).

The current study has several limitations. First, our sample population included only patients who underwent surgical intervention, which does not reflect the vast majority of patients with urinary stone disease. Second, the patients' serum and urine biochemical profiles were not investigated. Also, urinary pH had a diurnal variation. Urine collected in the morning had a significantly lower pH than urine collected in the day or evening [28]. We used a single urine sample collected at a variable time, which could have distorted the results. Third, the International Association for the Study of Obesity proposed the criterion for obesity as a BMI above 30 kg/m2, which was based on Caucasian data [29]. In contrast, for people from Asia-Oceania, where the main energy intake comes from carbohydrates, obesity is defined as a BMI above 25 kg/m2 [18]. This disparity between the cutoff points is quite large; therefore, we believe our conclusion may not be applicable to other ethnic populations. If we adopted the Western criterion for obesity in this study, only 7.1% (35/490) of the participants would have been classified as obese, compared with 42.0% according to the Asian criterion.

CONCLUSIONS

This study revealed obesity to be associated with UA and CO stones compared with COP and CP stones. This finding suggests that clinicians should encourage urinary stone patients to reduce their weight, especially those with history of CO and UA stones.

Notes

The authors have nothing to disclose.

References

    1. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992;327:1141–1152.
    1. Levy FL, Adams-Huet B, Pak CY. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1995;98:50–59.
    1. Mydlo JH. The impact of obesity in urology. Urol Clin North Am 2004;31:275–287.
    1. Trinchieri A, Coppi F, Montanari E, Del Nero A, Zanetti G, Pisani E. Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol 2000;37:23–25.
    1. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003;63:1817–1823.
    1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723–1727.
    1. Kopelman PG. Obesity as a medical problem. Nature 2000;404:635–643.
    1. Zilberman DE, Yong D, Albala DM. The impact of societal changes on patterns of urolithiasis. Curr Opin Urol 2010;20:148–153.
    1. Jung TS, Yang WJ, Song YS. The correlation between metabolic syndrome and urinary pH in adult Korean Men Who visited a health promotion center. Korean J Urol 2009;50:694–698.
    1. Pak CY, Sakhaee K, Peterson RD, Poindexter JR, Frawley WH. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 2001;60:757–761.
    1. Eisner BH, Porten SP, Bechis SK, Stoller ML. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol 2010;183:2244–2248.
    1. Pak CY, Arnold LH. Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp Biol Med 1975;149:930–932.
    1. Coe FL, Strauss AL, Tembe V, Le Dun S. Uric acid saturation in calcium nephrolithiasis. Kidney Int 1980;17:662–668.
    1. Negri AL, Spivacow FR, Del Valle EE, Forrester M, Rosende G, Pinduli I. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res 2008;36:303–307.
    1. Duffey BG, Pedro RN, Kriedberg C, Weiland D, Melguist J, Ikramuddin S, et al. Lithogenic risk factors in the morbidly obese population. J Urol 2008;179:1401–1406.
    1. Asplin JR. Obesity and urolithiasis. Adv Chronic Kidney Dis 2009;16:11–20.
    1. Eisner BH, Porten SP, Bechis SK, Stoller ML. The role of race in determining 24-hour urine composition in white and Asian/Pacific islander stone formers. J Urol 2010;183:1407–1411.
    1. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. World Rev Nutr Diet 2005;94:1–12.
    1. Powell CR, Stoller ML, Schwartz BF, Kane C, Gentle DL, Bruce JE, et al. Impact of body weight on urinary electrolytes in urinary stone former. Urology 2000;55:825–830.
    1. Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY. Association of urinary pH with body weight in nephrolithiasis. Kidney Int 2004;65:1422–1425.
    1. Sakhaee K, Maalouf NM. Metabolic syndrome and uric acid nephrolithiasis. Semin Nephrol 2008;28:174–180.
    1. Agarwal BN, Cabebe FG. Renal acidification in elderly subjects. Nephron 1980;26:291–295.
    1. Hesse A, Classen A, Knoll M, Timmermann F, Vahlensieck W. Dependence of urine composition on the age and sex of healthy subjects. Clin Chim Acta 1986;160:79–86.
    1. Maalouf NM, Cameron MA, Moe OW, Sakhaee K. Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 2004;13:181–189.
    1. Grases F, Sanchis P, Perelló J, Costa-Bauzá A. Role of uric acid in different types of calcium oxalate renal calculi. Int J Urol 2006;13:252–256.
    1. Grover PK, Ryall RL. Critical appraisal of salting-out and its implications for chemical and biological sciences. Chem Rev 2005;105:1–10.
    1. Chou YH, Su CM, Li CC, Liu CC, Liu ME, Wu WJ, et al. Difference in urinary stone components between obese and non-obese patients. Urol Res 2011;39:283–287.
    1. Murayama T, Sakai N, Yamada T, Takano T. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients. Int J Urol 2001;8:525–531.
    1. Report of a WHO Consultation on obesity: obesity-preventing and managing the global epidemic. Geneva: WHO/NUT/NCD; 1997.

Metrics
Share
Tables

1 / 3

PERMALINK